During the past decade, Headlands Research Orlando conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Headlands Research Orlando" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "Scion NeuroStim" with 2 trials sponsored, "Alzheon Inc." with 1 trials sponsored and "Janssen Vaccines & Prevention B.V." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Headlands Research Orlando" #1 collaborator was "National Institute on Aging (NIA)" with 2 trials as a collaborator, "Alzheimer's Association" with 1 trials as a collaborator and "Clinilabs, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Headlands Research Orlando" are "Alzheimer Disease" (4 trials), "Parkinson Disease" (2 trials), "Parkinson's Disease and Parkinsonism" (2 trials), "Early Alzheimer's Disease" (1 trials) and "Influenza, Human" (1 trials). Many other conditions were trialed in "Headlands Research Orlando" in a lesser frequency.

Most popular intervention types in "Headlands Research Orlando" are "Drug" (4 trials), "Biological" (3 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Donanemab" (2 trials), "15mg T3D-959" (1 trials), "30 mg T3D-959" (1 trials) and "45 mg T3D-959" (1 trials). Other intervention names were less common.

The vast majority of trials in "Headlands Research Orlando" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Headlands Research Orlando". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 1 completed trials in Headlands Research Orlando, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Headlands Research Orlando, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".